SSVPL
Powerful Medical has been given a dedicated 60-minute presentation slot in the programme. Join us to learn how AI-powered ECG interpretation can help general practitioners recognise acute cardiac events and make confident referral decisions directly in the outpatient setting.
HornĂ˝ Smokovec, Slovakia
October 15–17, 2026
The annual conference of the Slovak Society of General Practice is the largest professional event for general practitioners in Slovakia, held every October in the High Tatras. With around 2,000 participants, it is the key meeting point for primary care physicians, nurses and young GPs in training.
The 47th edition continues the tradition of interdisciplinary programming — clinical updates, practical workshops and sessions on the everyday realities of running a general practice. Its scale and audience make it the most direct way to reach the front line of Slovak primary care.
- Venue: Grand Hotel Bellevue, HornĂ˝ Smokovec, High Tatras, Slovakia
- Organiser: Slovenská spoločnosť všeobecného praktického lekárstva (Slovak Society of General Practice)
- Website: ssvpl.sk
Share this article
About PMcardio
PMcardio features FDA-authorized and CE-marked AI ECG models that interpret any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.